Literature DB >> 10993218

The hypoglycemic effect of (7R*,9aS*)-7-phenyl-octahydroquinolizin-2-one in mice.

H Kubo1, J Kobayashi, K Higashiyama, J Kamei, Y Fujii, S Ohmiya.   

Abstract

(-)-Multiflorine (1), which was isolated from leguminous plants, produced a hypoglycemic effect when administered to mice with streptozotocin-induced diabetes. (-)-Multiflorine has an enaminone type conjugation on the A-ring, which is unusual in lupine alkaloids. Proceeding on the assumption that the A-B ring is responsible for the activity, several compounds bearing quinolizidin-2-one were synthesized and their hypoglycemic effects were examined. The hypoglycemic effect of (7R*,9aS*)-7-phenyl-octahydroquinolizin-2-one was approximately 4 times stronger than that of (-)-multiflorine measured by oral glucose tolerance test in normal mice. This result indicates that compounds possessing the quinolizidin-2-one ring system as the basic structure may be possible lead compounds for a new type of diabetes drug.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993218     DOI: 10.1248/bpb.23.1114

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  2 in total

1.  55P0110, a Novel Synthetic Compound Developed from a Plant Derived Backbone Structure, Shows Promising Anti-Hyperglycaemic Activity in Mice.

Authors:  Barbara Brunmair; Zsuzsanna Lehner; Karin Stadlbauer; Immanuel Adorjan; Klaus Frobel; Thomas Scherer; Anton Luger; Leonhardt Bauer; Clemens Fürnsinn
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

2.  Evidence that the multiflorine-derived substituted quinazolidine 55P0251 augments insulin secretion and lowers blood glucose via antagonism at α2 -adrenoceptors in mice.

Authors:  Zsuzsanna Lehner; Karin Stadlbauer; Barbara Brunmair; Immanuel Adorjan; Miroslav Genov; Alexandra Kautzky-Willer; Thomas Scherer; Mika Scheinin; Leonhardt Bauer; Clemens Fürnsinn
Journal:  Diabetes Obes Metab       Date:  2019-11-07       Impact factor: 6.577

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.